Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.
Press releases published on September 8, 2025
Polyisocyanurate (PIR) Insulated Sandwich Panels Market Forecasted to Achieve US $4.92 Billion by 2029
EIN Presswire
·
September 8, 2025
The Business Research Company’s Polyisocyanurate (PIR) Insulated Sandwich Panels Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, September 8, 2025 /EINPresswire.com/ -- How Big Is The …
Pneumatic Angled Finish Nailer Market Set to Reach $1.13 Billion by 2029
EIN Presswire
·
September 8, 2025
The Business Research Company's Pneumatic Angled Finish Nailer Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, September 8, 2025 /EINPresswire.com/ -- What Is The Expected Cagr For …
Plunge Routers For Woodworking Industry Analysis Report 2025: Key Trends, Drivers, and Forecast Insights
EIN Presswire
·
September 8, 2025
The Business Research Company's Plunge Routers For Woodworking Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, September 8, 2025 /EINPresswire.com/ -- Plunge Routers For Woodworking …
Demand for Point Of Sale (POS) Cash Registers Market is forecasted to reach a value of US $25.38 billion by 2029
EIN Presswire
·
September 8, 2025
The Business Research Company's Point Of Sale (POS) Cash Registers Testing Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, September 8, 2025 /EINPresswire.com/ -- How Large Will The …
InnoCare Announces Approval of HIBRUKA (Orelabrutinib) for the Treatment of Marginal Zone Lymphoma in Singapore
GlobeNewswire
·
September 8, 2025
BEIJING, Sept. 07, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced today that HIBRUKA (orelabrutinib) has been approved by the Health Sciences …